These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8149961)
1. B precursor acute lymphoblastic leukemia third complementarity-determining regions predominantly represent an unbiased recombination repertoire: leukemic transformation frequently occurs in fetal life. Steenbergen EJ; Verhagen OJ; van Leeuwen EF; Behrendt H; Merle PA; Wester MR; von dem Borne AE; van der Schoot CE Eur J Immunol; 1994 Apr; 24(4):900-8. PubMed ID: 8149961 [TBL] [Abstract][Full Text] [Related]
2. Restricted utilization of germ-line VH3 genes and short diverse third complementarity-determining regions (CDR3) in human fetal B lymphocyte immunoglobulin heavy chain rearrangements. Raaphorst FM; Timmers E; Kenter MJ; Van Tol MJ; Vossen JM; Schuurman RK Eur J Immunol; 1992 Jan; 22(1):247-51. PubMed ID: 1730252 [TBL] [Abstract][Full Text] [Related]
3. [Characteristics of immunoglobulin heavy chain variable region genes in childhood B-cell acute lymphoblastic leukemia]. Liu Y; Zhu P; Hu YM Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):8-12. PubMed ID: 14990068 [TBL] [Abstract][Full Text] [Related]
4. Preferential usage of JH2 in D-J joinings with DQ52 is determined by the primary DNA sequence and is largely dependent on recombination signal sequences. Suzuki H; Shiku H Eur J Immunol; 1992 Sep; 22(9):2225-30. PubMed ID: 1516615 [TBL] [Abstract][Full Text] [Related]
5. The pattern of joining (JH) gene usage in the human IgH chain is established predominantly at the B precursor cell stage. Wasserman R; Ito Y; Galili N; Yamada M; Reichard BA; Shane S; Lange B; Rovera G J Immunol; 1992 Jul; 149(2):511-6. PubMed ID: 1624797 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells. Kiyoi H; Naoe T; Horibe K; Ohno R J Clin Invest; 1992 Mar; 89(3):739-46. PubMed ID: 1541668 [TBL] [Abstract][Full Text] [Related]
7. Use of the most JH-proximal human Ig H chain V region gene, VH6, in the expressed immune repertoire. Varade WS; Marin E; Kittelberger AM; Insel RA J Immunol; 1993 Jun; 150(11):4985-95. PubMed ID: 8496600 [TBL] [Abstract][Full Text] [Related]
8. Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event. Wasserman R; Galili N; Ito Y; Reichard BA; Shane S; Rovera G J Exp Med; 1992 Dec; 176(6):1577-81. PubMed ID: 1460419 [TBL] [Abstract][Full Text] [Related]
9. Clonal expansion of germline B-lineage acute lymphoblastic leukemia in severe combined immunodeficient mice. Felix CA; Wasserman R; Cesano A; Nowell PC; Hosler MR; Masterson M; Poplack DG; Santoli D Oncogene; 1995 Nov; 11(9):1753-9. PubMed ID: 7478603 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms that generate human immunoglobulin diversity operate from the 8th week of gestation in fetal liver. Cuisinier AM; Gauthier L; Boubli L; Fougereau M; Tonnelle C Eur J Immunol; 1993 Jan; 23(1):110-8. PubMed ID: 8419161 [TBL] [Abstract][Full Text] [Related]
11. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. Sanz I J Immunol; 1991 Sep; 147(5):1720-9. PubMed ID: 1908883 [TBL] [Abstract][Full Text] [Related]
12. Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy. Donisi PM; Di Lorenzo N; Riccardi M; Paparella A; Sarpellon C; Zupo S; Bertoldero G; Minotto C; Stracca-Pansa V Diagn Mol Pathol; 2006 Dec; 15(4):206-15. PubMed ID: 17122648 [TBL] [Abstract][Full Text] [Related]
13. Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. Corbett SJ; Tomlinson IM; Sonnhammer EL; Buck D; Winter G J Mol Biol; 1997 Jul; 270(4):587-97. PubMed ID: 9245589 [TBL] [Abstract][Full Text] [Related]
14. V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Duke VM; Gandini D; Sherrington PD; Lin K; Heelan B; Amlot P; Mehta AB; Hoffbrand AV; Foroni L Haematologica; 2003 Nov; 88(11):1259-71. PubMed ID: 14607755 [TBL] [Abstract][Full Text] [Related]
15. Predominance of VH-D-JH junctions occurring at sites of short sequence homology results in limited junctional diversity in neonatal antibodies. Feeney AJ J Immunol; 1992 Jul; 149(1):222-9. PubMed ID: 1607655 [TBL] [Abstract][Full Text] [Related]
16. No evidence for the use of DIR, D-D fusions, chromosome 15 open reading frames or VH replacement in the peripheral repertoire was found on application of an improved algorithm, JointML, to 6329 human immunoglobulin H rearrangements. Ohm-Laursen L; Nielsen M; Larsen SR; Barington T Immunology; 2006 Oct; 119(2):265-77. PubMed ID: 17005006 [TBL] [Abstract][Full Text] [Related]
17. The VDJ repertoire expressed in human preB cells reflects the selection of bona fide heavy chains. Milili M; Schiff C; Fougereau M; Tonnelle C Eur J Immunol; 1996 Jan; 26(1):63-9. PubMed ID: 8566085 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the complementary determining region III of the immunoglobulin heavy chain locus in acute lymphoblastic leukemia in Chilean children. Barriga FJ; RisueNo C; Patillo JC; Andrade W; Cabrera ME; Beressi V; Del Borgo P; Salgado C; Becker A; Campbell M; Bertin P Leukemia; 1996 Nov; 10(11):1719-23. PubMed ID: 8892674 [TBL] [Abstract][Full Text] [Related]
19. Diversity of immunoglobulin heavy chain gene segment rearrangement in B lymphoblastoid cell lines from X-linked agammaglobulinemia patients. Timmers E; Kenter M; Thompson A; Kraakman ME; Berman JE; Alt FW; Schuurman RK Eur J Immunol; 1991 Oct; 21(10):2355-63. PubMed ID: 1915549 [TBL] [Abstract][Full Text] [Related]
20. Antibody repertoire development in fetal and neonatal piglets. I. Four VH genes account for 80 percent of VH usage during 84 days of fetal life. Sun J; Hayward C; Shinde R; Christenson R; Ford SP; Butler JE J Immunol; 1998 Nov; 161(9):5070-8. PubMed ID: 9794445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]